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Abstract  
 
Introduction: With the aim to reduce inappropriate procedures and antibiotic therapy in the 
management of acute otitis media (AOM) in children, the Italian Society of Preventive and Social 
Pediatrics (SIPPS) proposed a top five list of recommendations for clinical practice.  
Areas covered: AOM is one of the most frequent reasons for antibiotic prescription in pediatric age.  
The over-estimation of AOM is associated with inappropriate treatment, increased costs, adverse 
events and spread of antibiotic resistance. Thus, the most recent guidelines provided stringent 
diagnostic criteria and considered the “watchful waiting” approach, limiting the immediate 
antibiotic therapy to a well-characterized subgroup of children. 
Expert commentary: The five recommendations proposed are: 1) Do not diagnose AOM without 
having documented the presence of middle ear effusion 2) Do not diagnose AOM without 
examining the entire tympanic membrane; 3) Do not treat immediately all cases of AOM with 
antibiotics; 4) Do not administer ear analgesic drops until examining the whole tympanic 
membrane  5) Do not use macrolides in the AOM therapy.  This list of top five recommendations 
could be a novel tool to spread the key messages on the guidelines and to promote the correct 
diagnostic procedures as well as a rational use of antibiotics in children.  
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1.Introduction 
Antibiotics are among the drugs most commonly prescribed to children. It has been reported that 
approximately 60% of children in hospital settings (1-2) and 20% of children in ambulatory visits 
receive at least one antibiotic (3). Unfortunately, a great number of these antibiotic prescriptions are 
unnecessary or inappropriate.  Improper antibiotic therapy is a leading factor in wasting health care 
resources and places patients at risk of developing adverse events and especially antimicrobial 
resistance. Therefore, the implementation of strategies to preserve the activity of antimicrobial 
agents has become an urgent public health priority.  In this regard the American Academy of 
Pediatrics (AAP) drew up a list of 10 recommendations to be adopted in pediatric clinical practice 
(4). The first of these messages discouraged the use of antibiotics in cases of apparent viral 
respiratory infections, because of the frequent resulting adverse events such as diarrhea and rash 
and especially of the spread of resistant bacterial strains (4). Moreover, many scientific societies 
and government agencies joined antimicrobial stewardship initiatives that have been shown to be 
effective in reducing the inappropriate use of antibiotic therapy (5).  
In particular, AOM is one of the most frequent pediatric diseases: more than 80% of children under 
3 years of age present at least one episode of AOM and about one-third of children has a recurrence 
(6-7). In Europe, the incidence of AOM in outpatient care is 268 episodes per 1000 people-year (CI 
95%: 254-283) (8) and in Italy, in children under 5 years of age, is around 16% (9). Thus, AOM is 
one of the most frequent indications for antibiotic therapy in children. The proportion of children 
with AOM treated with antibiotics ranges from about 50% in Germany (10), to 65% in the 
Netherlands (11), up to 80% in the US (12) and in Italy (13).  
Therefore, a team of experts in the management of the child's AOM from the Italian Society for 
Prevention and Social Pediatrics (SIPPS) has developed and proposed a top five list of 
recommendations on the management of AOM. 
 
2.Methodology 
A panel of experts identified, through a review of literature and consensus, five items for the list of 
recommendations. Once obtained the consent on the final list of five items, the statements were 
formulated. Drafted recommendations were formulated and then reviewed and discussed within the 
panel, until a final consensus was reached. Each message presented as a single, action-oriented 
sentence and is followed by an overview of the evidence behind the recommendation. 
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3.Results 
The five most relevant messages have been summarized in Table 1. 
 
3.1 First message  
Do not diagnose AOM without having documented the presence of middle ear effusion  
International literature indicates a high number of errors in diagnoses of AOM and in particular the 
high over-estimation of AOM frequency, often diagnosed in cases of merely hyperemic tympanic 
membrane or in children with otitis media with effusion (OME) (14,15). In order to avoid 
unnecessary and unjustified treatments it is therefore imperative to differentiate carefully subjects 
with AOM from those with OME or other forms (16,17). 
The diagnosis of AOM cannot be based only on symptoms that are non-specific and overlapping 
with those of other upper respiratory tract infections. The key diagnostic element of AOM is the 
presence of middle ear fluid, as shown by cultures of samples obtained by tympanocentesis (18).  
The diagnostic criteria of AOM are the moderate to severe bulging of the tympanic membrane, the 
acute onset acute otorrhea not due to acute external otitis,  the slight bulging associated with a 
recent onset (within 48 hours) of otalgia (ear tugging/rubbing/holding, excessive crying in the 
youngest child) or intense membrane hyperemia (16,17). The standard tool recommended by 
guidelines (16,17) in diagnosing AOM is the pneumatic otoscope, which can detect the presence of 
endotympanic exudate more significantly than the simple otoscope.  Pneumatic otoscopy allows the 
assessment of the contour of the TM, its color, its translucency and its mobility.  
To perform a correct pneumatic otoscopy, clinicians should firstly select the speculum size that best 
fits the external ear canal. It is necessary to assure that the pneumatic system is leak-free by 
squeezing and releasing the bulb against a fingertip, in order to confirm an effective suction (16,17). 
With the aim of getting a better view of the tympanic membrane, pediatricians should gently pull 
the ear backward to straighten the ear canal.  The otoscope should be inserted far enough to create a 
good seal and to prevent air leakage between the speculum and ear canal wall. Attention should be 
paid not to insert the device too deeply.  The ear canal and the eardrum should be carefully explored 
assessing color, translucency, and position of the tympanic membrane (16,17). A normal tympanic 
membrane is convex, translucent, and intact. The pneumatic procedure consists of gently squeezing 
the bulb in order to create positive pressure on the tympanic membrane and to observe the degree of 
its mobility. Subsequently, the bulb should be released to create negative pressure on the tympanic 
membrane and observe the degree of TM mobility. 
Inward movement of the TM on positive pressure in the external canal, and outward movement on 
negative pressure should occur, especially in the superior posterior quadrant (16,17). If the 
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tympanic membrane does not move with applications of slight positive or negative pressure, a 
middle ear effusion is highly likely.    
Therefore,  it is essential to ensure adequate instruction in the proper evaluation of the child’s 
middle ear status and to require adequate post-graduate practice (19).  
Appropriate tools for learning ear examination can be represented by the use of video-otoscopes and 
of educational videos available at specific websites suggested by American guidelines 
(http://www2.aap.org/sections/infectdis/ video, ePROM: Enhancing Proficiency in Otitis Media) 
(19,20,21). In uncertain cases, if a pneumatic otoscope is not available, the pediatrician could 
combine a simple otoscopic assessment with  tympanometry, or could address the patient to the 
otorhinolaryngologist that uses optical microscopy, otoendoscopy or impedance measurement (16). 
 
3.2 Second message 
Do not diagnose AOM without examining the whole tympanic membrane 
The main problem in AOM diagnoses is the difficulty of properly visualizing the tympanic 
membrane. The otoscopic assessment can be complicated or impeded by cerumen, epidermal debris 
or any other cause that completely or partially covers the tympanic membrane. Cerumen obstructing 
at least 50% of the ear canal has been described in approximately 44% of children and 52% of these 
children were diagnosed with AOM (22). As highlighted in the latest guidelines, the cerumen 
removal is essential for the proper diagnosis and management of the AOM (16,17).  Pediatricians 
can remove it by irrigation of the ear canal with warm water (with a syringe of 10-20 mL). 
Alternatively,  only if performed by experienced hands and using a surgical head otoscope, it is 
possible to remove cerumen by using a curette with a loop (Billeau curette) or speculums equipped 
with a small hook (16,22). Currently, there are plastic curettes illuminated by a small light source 
and not completely obstructing the ear canal; these devices, even without a necessary specific 
experience, make it possible to remove the "soft" cerumen. This practice needs head immobilization 
in order to prevent ear canal skin lesions and bleeding, that may be abundant during crying, and that 
may obstruct tympanic membrane visualization, other than alert the pediatrician  and parents. A few 
drops of 10% hydrogen peroxide, instilled and left into the ear canal for two or three minutes, make 
the cerumen softer. Alternatively, if necessary, cerumen removal may require the intervention of the 
otorhinolaryngologist. An explanatory video with all the details on removal practice is available on 
the website of the New England Journal of Medicine (22,23).  
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3.3 Third message: 
Do not treat immediately all cases of AOM with antibiotics. 
Considering the risk-benefit ratio, guidelines recommend the “wait and see” strategy in children 
aged from 6 months to 2 years with unilateral AOM and mild symptoms and signs and in children 
of 2 years and older with unilateral AOM (either mild or severe) or bilateral with mild signs and 
symptoms. 
On the other hand,  an immediate antibiotic therapy is always recommended in children younger 
than 2 years with bilateral (both severe and mild) AOM, in children older than 2 years with severe 
bilateral AOM, in those with othorrea from spontaneous perforation and those with a history of 
recurrence (16,17). In addition, antibiotic treatment is reasonably advisable in children under 2 
years of age with severe symptoms,  when a certain AOM diagnosis is not achievable, even 
performing all diagnostic procedures (16,17). 
Metanalysis and controlled randomized trials (24,25) demonstrated a greater benefit of the 
immediate antibiotic therapy in terms of pain and fever reduction in cases of bilateral AOM in 
children under 2 years of age and in children with associated othorrea. Compared with subjects with 
unilateral AOM, cases with bilateral AOM are more likely to be of bacterial etiology (25,26), and 
the age under two years is associated with slower spontaneous resolution and higher rate of clinical 
failure (27). This strategy is also confirmed by the results of a recent randomized, double blind, 
placebo-controlled study including children aged 3 to 35 months with a certain diagnosis of AOM, 
aimed at assessing the effect of antibiotic therapy on the resolution time of the middle ear  effusion. 
Children were followed-up for 3 months and the comparison between the antibiotic-treated group 
and the placebo group did not reveal any significant difference in terms of time of middle ear 
effusion resolution (28). 
It is clear that an assessment of the severity of the episode is critical to adequately choose between 
watchful waiting strategy and immediate antibiotic therapy. For this purpose, different and not 
overlapping definitions of severity are available (29,30). Mc Cormick et al (25) provided a 3-score 
score (OM-3) that evaluates symptoms (otalgia, fever), child's suffering (irritability, disapproval) 
and activity limitation and a 5 Items score (ETG-5) including fever, otalgia, irritability, discomfort 
and sleep disturbances. Both are able to detect a change in the severity of AOM. Mc Cormick and 
collaborators also developed a visual acuity scale named Acute Otitis Media-Faces Scale (AOM-
FS), with faces similar to those of the Wong-Baker Pain Scale, that, if associated with an otoscopic 
score (OS-8), is related to clinical changes (31). Shaikh et al. validated a seven items (AOM-SOS) 
score recorded by parents/tutors including ear touching or rubbing, crying, irritability, difficulty in 
sleeping, reduced activity or appetite, and fever (32). This score was related to otoscopic diagnoses 
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(AOM, OME, and normal middle ear status) and appropriately changed according to the clinical 
evolution (32). These scales have the limit of not attributing to each item a different weight based 
on its prognostic value. At this regard, it is interesting to point out the scale proposed by the 
Japanese guideline (33), which assigns different scores to the following parameters: age, otalgia 
intensity, fever, crying, hyperemia or bulging of the tympanic membrane, otorrhea. Even if the 
Japanese score seems to be a more versatile tool, at the moment there is no evidence of superiority 
of a severity score on the others. 
The “wait and see” strategy should be adopted only if an adequate follow-up is feasible. Moreover,  
antibiotic should be prescribed in children with clinical worsening or not improving within 48 to 72 
hours (16,17). Parents/tutors should be advised about the benign and self-limiting nature of most 
AOMs. (16,17). The follow-up procedure has not been yet standardized and remains at the 
discretion of the physician, who may decide to schedule a check-up visit, establish a telephone 
contact, or prescribe an antibiotic therapy to be administered in case of clinical worsening. A 
randomized placebo-controlled Finnish study on children aged 3 to 35 months with AOM diagnosis 
showed that changes in otoscopic MT appearance were related (86%) to the parental clinical report 
(AOM-SOS). Therefore, children with reported clinical improvement may not need a routine check-
up visit but a phone follow-up may be sufficient (34). 
 
3.4 Fourth message  
Do not administer ear analgesic drops until examining the whole tympanic membrane   
The management of AOM should include assessment and treatment of otalgia. Paracetamol or 
ibuprofen could be used (16,17,35,36). The use of anesthetic eardrops can be considered only in 
combination with systemic analgesic therapy, in case of moderate to severe otalgia, as they have 
the advantage of controlling pain more rapidly than systemic analgesics. Analgesic drops can be 
applied only after tympanic membrane assessment and after excluding a tympanic perforation as 
they may complicate global tympanic membrane visualization (16). 
 
3.5 Fifth message 
Do not use macrolides in the AOM therapy  
The 3 most common bacterial pathogens in AOM  are Streptococcus pneumoniae, Haemophilus 
influenzae and Moraxella catarrhalis. Therefore, amoxicillin or amoxicillin plus clavulanic acid are 
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recommended as first-line treatment.In  case of uncomplicated AOM and mild symptoms in absence 
of risk factors for bacterial resistance and without a history of recurrence, the first choice therapy is 
amoxicillin (80-90 mg/ kg/day). In children with complicated AOM with severe symptoms and / or 
in subjects at risk for bacterial resistance, or with a history of recurrence, who have taken 
amoxicillin in the previous 30 days, therapy should be initiated with high-dose amoxicillin-
clavulanate (80-90 mg/kg/day of amoxicillin) (16). 
A potential strategy for reducing the spread of antibiotic resistance could be to shorten the duration 
of therapy below the standard 10 days (17, 37). Studies comparing the efficacy of 10 days antibiotic 
therapy (amoxicillin, trimethoprym sulphamethoxazole, cephalosporin and macrolides) with that of 
5 -7 days regimen did not show any significant differences except for a minimal superiority of 
prolonged duration in children younger than 2 years (37) or in children with history of AOM in the 
previous month or at risk of bacterial resistance (38). A 2010 Cochrane review on evaluating 
standard duration therapy with azithromycin and ceftriaxone versus a 5-7 day-regimen, 
demonstrated a minimal short-term superiority of standard duration but a higher risk of side effects 
(39). 
Hoberman et al. (27) compared, in children 6 to 23 months of age with certain diagnosis of AOM, 
the efficacy of antibiotic therapy with amoxicillin-clavulanic acid at 90 mg/kg for 10 days and 
efficacy of 5 day-therapy considering the percentage of clinical failure, incidence of resistant 
strains, adverse effects, recurrence rate and persistence of middle ear fluid.  There was a greater 
percentage of clinical failure in children treated for 5 days (77 of 229 children [34%] vs. 39 of 238 
[16%]) with a difference of 17% (27). On the other hand, there was no significant difference 
between the two groups in terms of risk of monthly recurrence, of residual middle ear effusion 
frequency, of adverse events, and especially in terms of the onset of resistant bacteria during or after 
therapy (27). 
Therefore, antibiotic therapy should last 10 days in children at risk of worsening (less than 2 years 
and / or with spontaneous otorrhea), while 5 days therapy may be adopted in children younger than 
2 years without risk factors for unfavorable evolution (16,27). 
Macrolides have limited efficacy against AOM pathogen bacteria (S.pneumoniae, H.influenzae, M. 
catarrhalis), since antibiotic resistance rates widely varies between countries and in Europe a figure 
of 26% for S. pneumoniae and 38% for S. pyogenes is described (40). Macrolides should be used 
only in children allergic to penicillins. Cross reactivity between penicillin and second or third 
generation cephalosporins is negligible, due to the different chemical structure (41). On the other 
hand, it has been shown that the use of third generation cephalosporins leads to the selection of 
resistant strains such as extended-spectrum beta lactamase (ESBL) Enterobacteriaceae (42,43). 
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Therefore, if allergic tests are not available, when there is no history of severe or recent allergic 
reaction, second generation cephalosporins could be recommended. Macrolides should, therefore, 
be administered only in cases of severe allergy to penicillins and cephalosporins (16).  
4. Conclusions 
The main objective of proposing these five messages is to promote a  correct use of antibiotics in 
AOM management. The therapeutic choice is possible only after visualization of the entire 
tympanic membrane with the technique and instrumentation recommended by the guidelines. 
Antibiotics should be used only when watchful waiting strategy is not feasible such as in children 
younger than 2 years with bilateral otitis, in children older than 2 years with serious bilateral 
symptoms, in those with otorrhea and with recurrence history. 
 
5. Expert commentary 
The key weaknesses in the management of AOM are the difficulties of distinguishing AOM from 
OME from TM hyperemia, and of selecting patients who need antibiotic therapy from those eligible 
for the watchful waiting strategy. Moreover, there are not standardized AOM severity scores or a 
definite follow-up procedure by pediatricians. Recent guidelines have established rigorous 
diagnostic criteria and have offered precise categories of patients to guide the choice between 
immediate antibiotic therapy and watchful waiting strategy (16,17). Such selection results from 
consideration of patient's characteristics such as age, bilateral or monolateral AOM, clinical 
severity, epidemiology, prior antibiotic therapy.  Unfortunately, little adherence to the guidelines’ 
recommendations has been reported, as shown by the high percentage of antibiotic prescription 
(44). Therefore, it is essential to provide physicians with readily available tools to facilitate the 
acquisition of diagnostic and therapeutic criteria.  This list of recommendations could be a valuable 
instrument thanks to its synthetic ability and clear presentation of supporting evidences. It is also 
essential to institute education courses on the inspection of the tympanic membrane, the use of the 
pneumatic otoscope, the impedance-measuring device other than the technique to remove cerumen 
from the external auditory duct.  Nevertheless,  incisive campaigns to promote parents' awareness of 
proper antibiotic should be warranted.  
When an antibiotic therapy is required, the first choice drug should be amoxicillin (80-90 mg/ 
kg/day) or  high-dose amoxicillin-clavulanate (80-90 mg/kg/day of amoxicillin), in cases at risk of 
recurrence or resistance. Education programs and antibiotic stewardship campaigns should focus on 
reducing the inappropriate use of macrolides and of third generation cephalosporins because of 
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selection of resistant strains. Scientific research in this field should be aimed at providing further 
evidence on the safety of the observation approach, at standardizing a valid and simple severity 
score and a definite follow-up strategy.  
The most recent research has focused on establishing the appropriate duration of therapy (37-39). 
Several studies compared standard duration therapy with lower duration therapy. The results were 
discordant and did not show significant differences unless a minimum superiority of prolonged 
duration in children under the age of 2 years (37) or in children with history of AOM in the 
previous month or at risk of resistant infections (38).  Interestingly, Hoberman's 2016 study (27) 
showed higher percentage of clinical failure in children treated for 5 days without significant 
differences about the side effects and the occurrence of resistant bacteria either in course or after the 
therapeutic cycle.  Therefore, the certain effective strategies able to contain antibiotic resistance are 
the correct diagnosis of AOM and the precise selection of the patients to treat but not to shorten 
therapy duration, unless in very limited cases, whose definition still needs further studies.  
Current research is also focusing on validating severity scores of AOM and follow up strategies. A 
randomized placebo-controlled Finnish study (34) on children aged 3 to 35 months with AOM 
showed that the improvement in the otoscopic examination findings correlates well (86%) with the 
clinical report described by parents with the AOM-SOS score.   
Therefore, in children with clinical improvement reported by parents, a routine scheduled follow-up 
appointment may not be required, but a telephone follow-up may be sufficient (34).  
A recent Cochrane review has evaluated the effects of advising a delayed prescription of antibiotics 
in respiratory tract infections (including three studies on AOM) on clinical outcomes, antibiotic use, 
antibiotic resistance and patient satisfaction (45). The study has shown that a delayed antibiotics 
strategy may be an acceptable compromise in place of immediate prescribing to significantly reduce 
unnecessary antibiotic use for RTIs, and thereby reduce antibiotic resistance, while maintaining 
patient safety and satisfaction levels (45).  
 
6. Five-year view 
Looking forward over the next 5 years, significant advances are expected in clinical research in 
these regards that may extensively impact the quality of AOM management.  
A further diffusion in the everyday clinical practice of pneumatic otoscopy and of cerumen removal 
is desirable.  Indeed, we believe that the standardization of severity scores and follow up procedures 
could give greater solidity and security to the watchful waiting strategy leading to greater adherence 
to this approach.  
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7. Key issues 
• AOM is one of the most frequent indications for antibiotic therapy in children. 
Unfortunately, a great number of these antibiotic prescriptions are unnecessary or 
inappropriate.   
• In order to avoid unjustified treatments it is imperative to differentiate carefully subjects 
with AOM from those with OME or other forms. 
• The key diagnostic element of AOM is the presence of middle ear fluid. The standard tool 
recommended by guidelines in diagnosing AOM is the pneumatic otoscope. 
• With the aim of visualizing the whole tympanic membrane it is essential to remove cerumen 
from the external auditory canal.  
• The “wait and see” strategy is recommended in children aged from 6 months to 2 years with 
unilateral AOM and mild symptoms and signs and in children of 2 years and older with 
unilateral AOM (either mild or severe) or bilateral with mild signs and symptoms. 
• The “wait and see” strategy should be adopted only if an adequate follow-up is feasible. 
• Analgesic drops can be applied only after tympanic membrane assessment and after 
excluding a tympanic perforation. 
• Macrolides have limited efficacy against AOM pathogen bacteria. Therefore, they should be 
administered only in cases of severe allergy to penicillins and cephalosporins. 
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Acute otitis media in children 
 
1 
Do not diagnose AOM without having documented the presence ofmiddle ear 
effusion 
Diagnosis of AOM cannot be based only on symptoms, that are non-specific and overlapping  with 
those of other upper respiratory tract infections. In addition, fever can also be present in case of otitis 
media with effusion (OME). The presence of middle ear effusion should always be searched with a 
pneumatic otoscope.  Accurate signs of middle ear fluid are the clear tympanic membrane  bulging or 
the spontaneous perforation otorrhea.
2 
Do not diagnose AOM without examining the whole tympanic membrane 
With the aim of visualizing the whole tympanic membrane and its main features (integrity, position, 
color, transparency, brightness, and mobility)it is essential to remove cerumen from the external 
auditory canal. Cerumen removal can be carried out by adequately trained pediatricians or by an 
otorhinolaryngologist with different procedures depending on the operator’s training and from the 
available tools. 
3 
Do not treat immediately all cases of AOM with antibiotics. 
It is recommended to adopt an initial clinical “wait and see” strategy for children aged from 6 months 
to 2 years with unilateral AOM and mild symptoms and signs and in children of 2 years and older with 
unilateral AOM (either mild or severe) or bilateral with mild signs and symptoms. The watchful waiting 
approach is feasible only if previously  shared with parents and if it is possible to ensure an adequate 
follow-up, at least telephonic, within 48 to 72 hours after the onset of symptoms. 
4 
Do not administer ear analgesic drops until examining the whole tympanic 
membrane  
It is not advisable to administer ear analgesic drops in children under 3 years of age without a 
previous tympanic membrane visualization because there is not a solid evidence of efficacy, it is not 
safe in case of spontaneous perforation,  and may alter the otoscopic assessment because of cerumen 
fluidification.  
5 
Do not use macrolides in the AOM therapy  
The most common bacterial pathogens in AOM are Streptococcus pneumoniae, Haemophilus 
influenzae and Moraxella catarrhalis. These germs show moderate-high sensitivity to betalactams 
(mainly amoxicillin, amoxicillin-clavulanic acid and second-generation cephalosporins) but a medium 
to high resistance to macrolides.  
 
Table 1. Top five list in AOM management in children 
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